- CEO
- Akimoto Uchikawa
- Full Time Employees
- 21,834
- Sector
- Industrials
- Industry
- Conglomerates
- Address
- Kasumigaseki Common Gate West Tower Tokyo Japan 100-8585
- IPO Date
- Jan 7, 2014
- Business
- Teijin Limited (TINLF) manufactures and markets advanced fibers, composites, performance polymers, films, healthcare products, and IT solutions worldwide. The company produces aramid fibers such as Twaron, carbon fibers and composites for aerospace and automotive applications, high-performance polyethylene including Endumax branded UHMWPE, high-performance polyester and PEN fibers, artificial leather, flame-resistant fibers, polycarbonate resin, polyphenylene sulfide resin, PET and PEN films and sheets, polyester fibers, resin and plastic processing products, and fibers and products converting solutions; it also offers pharmaceuticals, medical equipment, and home healthcare devices targeting quality-of-life improvements. Teijin operates through materials and healthcare business fields, serving industries including automotive, aerospace, electronics, textiles, civil engineering, and medical sectors across Japan, North America, Europe, Asia, and other regions with 153 group companies and approximately 20,000 employees. Founded in 1918 and headquartered in Tokyo, Japan, the company maintains a global footprint with key facilities in the United States, Europe, and Asia. Recent developments include the March 2025 divestiture of Teijin Automotive Technologies North America to AURELIUS Private Equity, enhancing focus on core competencies; a December 2025 agreement with Asahi Kasei to integrate Teijin Frontier Co., Ltd., with Asahi Kasei Advance Corporation into a joint venture effective October 2026, where Teijin holds an 80% stake to strengthen textile and functional materials platforms; and a strategic collaboration with Cell Therapies to expand access to advanced cell and gene therapies in Japan and the Asia Pacific region.